Latest News

Cannabis constituent has no effect on multiple sclerosis progression, study shows

The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis, shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Spastic paraplegia: New light shed on cause

  • Sleep twitches light up the brain

  • Single-neuron 'hub' orchestrates activity of an entire brain circuit

  • 'Frenemy' in Parkinson's disease takes to crowdsourcing

  • Self-compassion key to positive body image, coping

  • Brief depression questionnaires could lead to unnecessary antidepressant prescriptions

  • CHICA system improves developmental delay screening, surveillance

  • The dangers of teens using marijuana

  • Jersey drivers admit to risky behaviors, poll finds

  • Talk therapy -- not medication -- best for social anxiety disorder, large study finds

  •